Form 13G Aptevo Therapeutics Inc. For: 14 August

Published 2 months ago Neutral
Form 13G Aptevo Therapeutics Inc. For: 14 August
Auto

Related Stocks

AAPL.US Apple Inc

More News

Genentech’s Fenebrutinib Shows Unprecedented Positive Phase III Results as the Potential First and Only BTK Inhibitor in Both Relapsing and Primary Progressive Multiple Sclerosis

45 minutes ago Positive

Bri-Chem announces key management changes

51 minutes ago Neutral

Start of Day Message

55 minutes ago Neutral

BioVersys BV100 Phase 2b to be Conducted Via Wellcome Funded Trial Network

55 minutes ago Neutral

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebrutinib shows unprecedented positive Phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis

55 minutes ago Positive